Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$6.5 - $12.67 $110,500 - $215,390
-17,000 Reduced 18.97%
72,600 $517,000
Q2 2022

Aug 08, 2022

BUY
$6.4 - $14.73 $530,560 - $1.22 Million
82,900 Added 1237.31%
89,600 $725,000
Q1 2022

May 16, 2022

BUY
$10.12 - $28.9 $33,396 - $95,370
3,300 Added 97.06%
6,700 $93,000
Q4 2021

Feb 14, 2022

BUY
$25.17 - $36.85 $85,578 - $125,290
3,400 New
3,400 $95,000
Q2 2021

Aug 16, 2021

SELL
$32.22 - $44.59 $48,330 - $66,885
-1,500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$37.26 - $67.74 $55,890 - $101,609
1,500 New
1,500 $60,000
Q4 2020

Feb 16, 2021

SELL
$45.01 - $65.47 $427,595 - $621,965
-9,500 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$35.79 - $48.81 $408,006 - $556,434
-11,400 Reduced 54.55%
9,500 $462,000
Q2 2020

Aug 14, 2020

BUY
$24.95 - $48.38 $521,455 - $1.01 Million
20,900 New
20,900 $1.01 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.